MedTrace Logo

Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children

NCT04794595 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-03-16

No results posted yet for this study

Summary

The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.

Conditions

Interventions

PROCEDURE

CBP

continuous blood purification can prevent or treat fluid overload in children with septic shock or other sepsis-associated organ dysfunction who are unresponsive to fluid restriction and diuretic therapy management of septic AKI patients, particularly those with hemodynamic instability or fluid overload. Also, it can remove cytokines

Sponsors & Collaborators

  • Shanghai Children's Hospital

    collaborator OTHER

  • Shanghai Children's Medical Center

    collaborator OTHER

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Lu guoing · Children's Hospital of Fudan University

Eligibility

Min Age
28 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04794595 on ClinicalTrials.gov